Publications by authors named "Suvimol Niyomnaitham"

Claim this Profile
F
Favipiravir pharmacokinetics in Thai adults with mild COVID-19: A sub-study of interpatient variability and ethnic differences in exposure.
Ing-Orn Prasanchaimontri, Weerawat Manosuthi, Henry Pertinez, Andrew Owen, Suvimol Niyomnaitham

Pharmacol Res Perspect· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of tixagevimab-cilgavimab for COVID-19 pre-exposure prophylaxis in immunocompromised 20 to <40 kg children and adolescents: A pilot, prospective, open-labeled study.
Jassada Buaboonnam, Supattra Rungmaitree, Nuntawan Piyaphanee, Sirirat Charuvanij, Onsiri Pitisuttithum, Suvimol Niyomnaitham

Hum Vaccin Immunother· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The immunogenicity and reactogenicity of four COVID-19 booster vaccinations against SARS-CoV-2 variants following CoronaVac or ChAdOx1 nCoV-19 primary series.
Nasikarn Angkasekwinai, Suvimol Niyomnaitham, Jaturong Sewatanon, Supaporn Phumiamorn, Kasama Sukapirom

Asian Pac J Allergy Immunol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of BNT162b2 as a first booster after a ChAdOx1 primary series in a Thai geriatric population living with frailty.
Suvimol Niyomnaitham, Kulkanya Chokephaibulkit, Chatkamol Pheerapanyawaranun, Zheng Quan Toh, Paul V Licciardi

J Nutr Health Aging· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and reactogenicity of repeated intradermal mRNA COVID-19 vaccines administered as a second booster dose in a Thai geriatric population.
Prasert Assantachai, Suvimol Niyomnaitham, Zheng Quan Toh, Monthira Thammasalee, Napaporn Pengsorn

Front Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and Reactogenicity of Messenger RNA Coronavirus Disease 2019 Vaccine Booster Administered by Intradermal or Intramuscular Route in Thai Older Adults.
Prasert Assantachai, Suvimol Niyomnaitham, Wichai Chatthanawaree, Somboon Intalapaporn, Weerasak Muangpaisan

J Infect Dis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and reactogenicity of fractional, heterologous primary COVID-19 vaccination schedules with BNT162b2 boosters in 5-11-year-old Thai children: A multicenter, prospective, double-blind, randomized control trial.
Orasri Wittawatmongkol, Pornumpa Bunjoungmanee, Pope Kosalaraksa, Kamolwish Laoprasopwattana, Sophida Boonsathorn, Suvimol Niyomnaitham

Vaccine· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women.
Chenchit Chayachinda, Kanokwaroon Watananirun, Chayawat Phatihattakorn, Sanitra Anuwutnavin, Suvimol Niyomnaitham

Hum Vaccin Immunother· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative efficacy and acceptability of licensed dose intranasal corticosteroids for moderate-to-severe allergic rhinitis: a systematic review and network meta-analysis.
Kay Khine Soe, Thanachit Krikeerati, Chatkamol Pheerapanyawaranun, Suvimol Niyomnaitham, Phichayut Phinyo

Front Pharmacol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants.
Suvimol Niyomnaitham, Anan Jongkaewwattana, Atibordee Meesing, Nawamin Pinpathomrat, Sira Nanthapisal

Int J Infect Dis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and reactogenicity of accelerated regimens of fractional intradermal COVID-19 vaccinations.
Suvimol Niyomnaitham, Suparat Atakulreka, Patimaporn Wongprompitak, Katherine Kradangna Copeland, Zheng Quan Toh

Front Immunol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early treatment of Favipiravir in COVID-19 patients without pneumonia: a multicentre, open-labelled, randomized control study.
Rujipas Sirijatuphat, Weerawat Manosuthi, Suvimol Niyomnaitham, Andrew Owen, Katherine Kradangna Copeland

Emerg Microbes Infect· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults.
Suvimol Niyomnaitham, Zheng Quan Toh, Patimaporn Wongprompitak, Laddawan Jansarikit, Kanjana Srisutthisamphan

Hum Vaccin Immunother· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial.
Suvimol Niyomnaitham, Zheng Quan Toh, Paul Vincent Licciardi, Patimaporn Wongprompitak, Kanjana Srisutthisamphan

J Infect· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of intradermal administration of fractional dose CoronaVac, ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccination.
Somruedee Chatsiricharoenkul, Suvimol Niyomnaitham, Harry Joshua Posen, Zheng Quan Toh, Paul V Licciardi

Front Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Safety and Immunogenicity of Fractional Intradermal COVID-19 Vaccines as a Booster: A Pilot Study.
Suvimol Niyomnaitham, Somruedee Chatsiricharoenkul, Zheng Quan Toh, Sansnee Senawong, Chatkamol Pheerapanyawaranun

Vaccines (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of safety and immunogenicity of CoronaVac and ChAdOx1 against the SARS-CoV-2 circulating variants of concern (Alpha, Delta, Beta) in Thai healthcare workers.
Nasikarn Angkasekwinai, Jaturong Sewatanon, Suvimol Niyomnaitham, Supaporn Phumiamorn, Kasama Sukapirom

Vaccine X· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioequivalence Study of 100-mg Cilostazol Tablets in Healthy Thai Adult Volunteers.
Somruedee Chatsiricharoenkul, Yanisorn Nanchaipruek, Patcharaporn Manopinives, Suparat Atakulreka, Suvimol Niyomnaitham

Curr Ther Res Clin Exp· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor mutational profile of triple negative breast cancer patients in Thailand revealed distinctive genetic alteration in chromatin remodeling gene.
Suvimol Niyomnaitham, Napa Parinyanitikul, Ekkapong Roothumnong, Worapoj Jinda, Norasate Samarnthai

PeerJ· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilisation trends of rosiglitazone and pioglitazone in Australia before and after safety warnings.
Suvimol Niyomnaitham, Andrew Page, Adam La Caze, Karen Whitfield, Alesha J Smith

BMC Health Serv Res· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioequivalence study of 50 mg sertraline tablets in healthy Thai volunteers.
Suvimol Niyomnaitham, Somruedee Chatsiricharoenkul, Korbtham Sathirakul, Piyapat Pongnarin, Supornchai Kongpatanakul

J Med Assoc Thai· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis